BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33179118)

  • 1. Evaluation of the efficacy of fractional CO
    Sindou-Faurie T; Louis-Vahdat C; Oueld Es Cheikh E; Canlorbe G; Mergui JL; Uzan C; Azaïs H
    Arch Gynecol Obstet; 2021 Apr; 303(4):955-963. PubMed ID: 33179118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar and vaginal fractional CO2 laser treatments for genitourinary syndrome of menopause.
    Streicher LF
    Menopause; 2018 May; 25(5):571-573. PubMed ID: 29406425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
    Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
    Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CO
    Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
    Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional CO
    Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
    Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
    Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
    Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
    Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
    Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G
    Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results.
    Athanasiou S; Pitsouni E; Grigoriadis T; Zacharakis D; Falagas ME; Salvatore S; Protopapas A; Loutradis D
    Menopause; 2019 Mar; 26(3):248-255. PubMed ID: 30252804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional CO
    Lang P; Dell JR; Rosen L; Weiss P; Karram M
    Lasers Surg Med; 2017 Dec; 49(10):882-885. PubMed ID: 28881431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and long-term efficacy of fractional CO
    Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
    Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S
    Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.